FibroGen's total assets for Q2 2025 were $178.06M, an increase of 7.77% from the previous quarter. FGEN total liabilities were $359.08M for the fiscal quarter, a 5.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.